USPTO serial 88855832
FREYA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, SANG MIN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FREYA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Copenhagen Ø, DK
2960 Rungsted Kyst, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw HOGAN LOVELLS US LLP555 13TH STREET, NWWASHINGTON, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medicinal preparations for medical and veterinary use for the treatment of diseases, ailments and dysbiosis associated with the microbiome; Pharmaceutical and medicinal preparations for the prevention and treatment of disorders and dysbiosis in the reproductive and urogenital organs; Dietary and nutritional supplements for the maintenance of health and prevention of disease; Pharmaceutical and medicinal preparations for the prevention and treatment of disease in connection with immune response; Pharmaceutical and biopharmaceutical preparations for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, gynecological disorders, reproductive disorders, cardiovascular disorders, and endocrine disorders; nutritional supplements, namely, probiotic compositions and probiotic preparations comprised of microorganisms or cultures of microorganisms, namely, bacteria or bacterial derived product for medical and veterinary use; Diagnostic agents for medical purposes, namely, diagnostic agents for assessing human or animal microbial communities and disturbances thereof; Diagnostic kits consisting primarily of medical diagnostic reagents and assays that test for the presence of biomarkers to determine overall health and microbiome health | ACTIVE | — |
| 042 | Pharmaceutical research and development; Pharmaceutical research and development in the fields of microbiologics, immunotherapeutics, and other therapeutic agents; Scientific research and development services relating to pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use, suppositories, topical creams, and sanitary products, namely, sanitary towels, sanitary napkins, tampons, sanitary panties, panty shields, panty liners, sanitary pads; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; Scientific and technological services and related consultation services, namely, of product development, and testing in the field pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; Research and development in the field of prenatal and postnatal care; Testing and evaluation of pharmaceutical, biopharmaceutical and chemical products to assure compliance with industry standards; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Medical screening services of biological materials in the field of micriobiome health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 4, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 4, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 4, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 28, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 28, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 1, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 1, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 8, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 4, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 4, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 4, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 14, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 10, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 10, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 10, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 2, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 2, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 2, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 19, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 31, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 31, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 31, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 31, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 28, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 28, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 28, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 28, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 28, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2020 | NWAP | NEW APPLICATION ENTERED | — |